Kapun Sonja
Med Arh. 2006;60(6):373-5.
Dialysis outcome is strongly affected by the function of the vascular access (VA). Thrombosis occurs as a result of decreased vascular access flow caused by a progressive stenosis of the access venous outflow tract. Applying a periodic measurement of recirculation with Blood Temperature Monitor (BTM-Fresenius Medical Care) every three months is it possible to prevent thrombosis and to avoid unnecessary expenses and a time-consuming procedure.
Using BTM, incorporated in Fresenius 4008 S machines, during dialysis procedure, we measured the recirculation on AV fistulas. The temperature bolus (thermodilution method) is produced by a temporary change in dialysate temperature (typically about 2,5 degrees C for 2,5 minutes). The measurement is initiated by pressing a single key. The result is available in 5-6 minutes. When recirculation measurement was greater than the threshold of 10%, we repeated the measurement on two next consecutive dialysis. If they were positive, a patient referred for Doppler evaluation, to elective fistulogram, or both. The patients with hemodynamically significant stenosis undergo angioplasty.
Over the period of 42 months 591 measurements were obtained in 44 patients (22M; 22F), mean patient age 62,3 (61,5M; 63,3F) years. All patients (100%) are having native AVF at their arms. In the observed period we found 22 suspected AVE After further evaluation we found 20 stenosis in 11 patients (4M; 4F). We performed 13 PTA without and 7 with stent placement. In 2 fistulas angiographies didn't confirm our suspicion, but they thrombosed after 3,7 (1-6,5) months, in average. Three fistulas thrombosed, in spite of a normal recirculation, two after the collapse caused by symptomatic hypotension, and one after the intensive physical work. In 4 patients (2M; 2F) we found 1-4 restenoses after percutaneous procedures. Restenoses were treated by PTA again. They occurs after 9,4 (2,5-17,5) months, in average.
Our results in finding stenosis and restenoses confirm that with three months measurements only a few stenoses will be unrecognised and rapidly progressed into a thrombosis. BTM is easy, quick and could be done by existing staff during every dialysis procedure, non-invasive, without blood sampling or indicator injections, without treatment interruption and discomfort or stress for the patient. Venography or Duplex sonography was used to confirm the lesions. PTA with or without stent placement is safe, simple, and efficacious, with rare complications.
BTM measurements are sufficiently reproducible and offer the opportunity to extend access monitoring to all haemodialysis patients. We propose to screen well functioning accesses every three months, accesses that are problematic or had a history of previous stenosis every 4 weeks. For now, accesses detected by BTM can be then examined by Venography or Duplex sonography. Screening with recirculation appears to enable earlier detection and therapy.
透析结果受血管通路(VA)功能的强烈影响。由于通路静脉流出道逐渐狭窄导致血管通路血流量减少,进而引发血栓形成。每三个月使用血液温度监测仪(BTM - 费森尤斯医疗)定期测量再循环,有可能预防血栓形成,并避免不必要的费用和耗时的程序。
在费森尤斯4008 S机器中使用BTM,在透析过程中,我们测量动静脉内瘘的再循环。温度团注(热稀释法)通过透析液温度的临时变化产生(通常约2.5摄氏度,持续2.5分钟)。通过按一个键启动测量。结果在5 - 6分钟内可得。当再循环测量值大于10%的阈值时,我们在接下来连续的两次透析中重复测量。如果结果为阳性,则将患者转诊进行多普勒评估、选择性瘘管造影或两者皆做。具有血流动力学显著狭窄的患者接受血管成形术。
在42个月期间,对44例患者(22例男性;22例女性)进行了591次测量,患者平均年龄62.3岁(男性61.5岁;女性63.3岁)。所有患者(100%)手臂均有自体动静脉内瘘。在观察期内,我们发现22例疑似动静脉内瘘狭窄(AVE)。进一步评估后,我们在11例患者(4例男性;4例女性)中发现20处狭窄。我们进行了13次未放置支架和7次放置支架的经皮腔内血管成形术(PTA)。在2例瘘管中,血管造影未证实我们的怀疑,但它们平均在3.7(1 - 6.5)个月后发生血栓形成。尽管再循环正常,仍有3例瘘管发生血栓形成,2例是在有症状性低血压导致内瘘塌陷后,1例是在剧烈体力活动后。在4例患者(男2例;女2例)中,我们在经皮手术后发现1 - 4处再狭窄。再狭窄再次通过PTA治疗。它们平均在9.4(2.5 - 17.5)个月后发生。
我们在发现狭窄和再狭窄方面的结果证实,每三个月测量一次,只有少数狭窄会未被识别并迅速发展为血栓形成。BTM操作简便、快速,现有工作人员可在每次透析过程中完成,是非侵入性的,无需采血或注射指示剂,不会中断治疗,也不会给患者带来不适或压力。静脉造影或双功超声用于确认病变。有或无支架置入的PTA安全、简单且有效,并发症罕见。
BTM测量具有足够的可重复性,并为将通路监测扩展到所有血液透析患者提供了机会。我们建议每三个月对功能良好的通路进行筛查,对有问题或有既往狭窄病史的通路每4周筛查一次。目前,通过BTM检测到的通路随后可通过静脉造影或双功超声进行检查。通过再循环筛查似乎能够实现更早的检测和治疗。